{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260825943679/en/BeOne-Medicines-Announces-U.S.-FDA-Approval-for-TEVIMBRA-Based-Regimen-for-First-Line-HER2-GEA", "message": "News view counter 901191 successfully enlarged"}